IP Library Granted Patent US 7,820,793
Granted Patent B2
US 7,820,793 · App. 10/503,866 · Granted Oct 26, 2010

IFN-λ polypeptides and compositions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,820,793
App. No.
10/503,866
Granted
Oct 26, 2010
Kind
B2
Abstract

A novel IFN-α/β independent ligand receptor system which upon engagement leads, among other things, to the establishment of an anti-viral state is disclosed. Further disclosed are three closely positioned genes on human chromosome 19 that encode distinct but highly homologous proteins, designated IFN-λ1, IFN-λ2, IFN-λ3, based, inter alia, in their ability to induce antiviral protection. Expression of these proteins is induced upon viral infection. A receptor complex utilized by all three IFN-λ proteins for signaling is also disclosed. The receptor complex is generally composed of two subunits, a novel receptor designated IFN-λR1 or CRF2-12, and a second subunit, IL-10R2 or CRF2-4, which is also a shared receptor component for the IL-10 and IL-22 receptor complexes. The gene encoding IFN-λR1 is generally widely expressed, including many different cell types and tissues. Expression of these proteins is induced by immune events, including, for example, upon viral infection. Apoptotosis may also be induced under effective conditions.

Claims (22)

1. An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:

a polypeptide having the complete amino acid sequence of SEQ ID NO: 12;

amino acids 2-196 of SEQ ID NO: 12;

amino acids 23-196 of SEQ ID NO: 12;

amino acids 6-196 of SEQ ID NO: 12;

amino acids 12-196 of SEQ ID NO: 12;

amino acids 7-196 of SEQ ID NO: 12;

amino acids 13-196 of SEQ ID NO: 12;

amino acids 31-196 of SEQ ID NO: 12;

an IFN-λ3 polypeptide encoded by plasmid pEF-FL-IFN-λ3gene; a polypeptide encoded by the cDNA contained in plasmid pEF-FL-IFN-λ3; and

a mature polypeptide encoded by the cDNA contained in clone pEF-FL-IFN-λ3.

2. A composition comprising an isolated polypeptide of comprising an amino acid sequence selected from the group consisting of:

a polypeptide having the complete amino acid sequence of SEQ ID NO: 12;

amino acids 2-196 of SEQ ID NO: 12;

amino acids 23-196 of SEQ ID NO: 12;

amino acids 6-196 of SEQ ID NO: 12;

amino acids 12-196 of SEQ ID NO: 12;

amino acids 7-196 of SEQ ID NO: 12;

amino acids 13-196 of SEQ ID NO: 12;

amino acids 31-196 of SEQ ID NO: 12;

an IFN-λ3 polypeptide encoded by plasmid pEF-FL-IFN-λ3gene; a polypeptide encoded by the cDNA contained in plasmid pEF-FL-IFN-λ3; and

a mature polypeptide encoded by the cDNA contained in clone pEF-FL-IFN-λ3, and a carrier or diluent.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 5, 2013
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 031170/0331 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2010
From: KOTENKO, SERGEI; GALLAGHER, GRANT
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 023769/0454 →